In its role as the collective voice of the international biotechnology industry, the International Council of Biotechnology Associations (ICBA) organised its fourth delegation trip to Geneva. Many organisations, such as the World Trade Organization (WTO), the World Health Organization (WHO), the World Intellectual Property Organization (WIPO) and the International Organization for Standardization (ISO) have their headquarters in Geneva.
On 3 November BIO Deutschland participated for the second time in a fact-finding mission under the auspices of the OECD Review of Innovation Policy for Germany, focusing on biotechnology and pharmaceuticals. The dialogue is part of a transfer initiative led by the German Federal Ministry for Economic Affairs and Energy.
The third edition of the HealthTech Innovation Days (HTID3) took place on 4–5 October in Paris and with virtual participation. Kathrin Adlkofer, a member of the BIO Deutschland board, moderated the panel on “Clinical research as a care option and an added value for innovative companies”.
The National Association Council (NAC) and Healthcare Council (HC) of EuropaBio, the European umbrella association for biotechnology, convened in late November. The NAC is a body that brings together the national biotechnology associations that are organised in EuropaBio.